Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
International Cancer Conference Journal|June 1, 2019
Gemcitabine and docetaxel in a patient with primary ovarian leiomyosarcoma: a case report and review of literatureYoko Furutake, Tomoyuki Fukagawa, Yasuko Suga, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 8, 2012
Activation of the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase pathway overcomes cisplatin resistance in ovarian carcinoma cellsMichiko Nonaka, Hiroaki Itamochi, Wakae Kawaguchi, et al.
Human Cell|March 11, 2016
Establishment and characterization of a novel ovarian clear cell carcinoma cell line, TU-OC-2, with loss of ARID1A expressionSeiya Sato, Hiroaki Itamochi, Nao Oumi, et al.
Human Cell|January 1, 2013
Establishment and characterization of a novel ovarian serous adenocarcinoma cell line, TU-OS-4, that overexpresses EGFR and HER2Hiroaki Itamochi, Misaki Kato, Mayumi Nishimura, et al.
Oncology Reports|June 14, 2014
The PI3K/mTOR dual inhibitor NVP-BEZ235 reduces the growth of ovarian clear cell carcinomaTetsuro Oishi, Hiroaki Itamochi, Akiko Kudoh, et al.
Biochemical and Biophysical Research Communications|December 31, 2008
Halofuginone prevents extracellular matrix deposition in diabetic nephropathySeiya Sato, Harukiyo Kawamura, Minoru Takemoto, et al.
Cancers|July 2, 2021
Establishment of a Novel In Vitro Model of Endometriosis with Oncogenic <i>KRAS</i> and <i>PIK3CA</i> Mutations for Understanding the Underlying Biology and Molecular PathogenesisMohammad Mahmud Hossain, Kentaro Nakayama, Kamrunnahar Shanta, et al.
Human Cell|February 23, 2013
Establishment and characterization of a novel ovarian clear cell adenocarcinoma cell line, TU-OC-1, with a mutation in the PIK3CA geneHiroaki Itamochi, Misaki Kato, Mayumi Nishimura, et al.
Diseases (Basel, Switzerland)|February 9, 2021
Whole-Exome Sequencing of Rare Site Endometriosis-Associated CancerSonomi Kurose, Kentaro Nakayama, Sultana Razia, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|April 1, 2021
Downregulation of ZNF395 Drives Progression of Pancreatic Ductal Adenocarcinoma through Enhancement of Growth PotentialShusaku Kurogi, Naoki Hijiya, Shinya Hidano, et al.
Pageof 7